Page last updated: 2024-10-24

celecoxib and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous

celecoxib has been researched along with Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous in 1 studies

Research Excerpts

ExcerptRelevanceReference
"This study aimed to investigate the role of a cyclooxygenase inhibitor in ovarian hyperstimulation syndrome (OHSS) treatment and compare it with cabergoline."3.91Can a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome? ( Çilgin, H, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Çilgin, H1

Other Studies

1 other study available for celecoxib and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous

ArticleYear
Can a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome?
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Animals; Cabergoline; Celecoxib; Cyclooxygenase Inhibitors; Female; Injections, Subcutaneous; Ovaria

2019